sorafenib has been researched along with Latent Tuberculosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Connor, TM; O'Reilly, SP; Power, DG; Teo, M | 1 |
1 other study(ies) available for sorafenib and Latent Tuberculosis
| Article | Year |
|---|---|
Sorafenib-induced tuberculosis reactivation.
Topics: Aged; Antineoplastic Agents; Antitubercular Agents; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Latent Tuberculosis; Male; Niacinamide; Phenylurea Compounds; Secondary Prevention; Sorafenib; Treatment Outcome | 2012 |